Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.

By using AI to analyze tissue patterns, researchers gain new insights into why some patients respond better to specific ...

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before ...

Faced with a medical establishment that doesn’t serve them, a volatile political environment, and a technological revolution, some women are taking longevity into their own hands, Holly Baxter reports ...

Bria-IMT plus a checkpoint inhibitor improved survival versus Trodelvy and chemo in patients with heavily pretreated ...

Cancer conversations are evolving beyond awareness months, with increased focus on personal journeys, breakthroughs and patient experiences.

Scientists use patient-derived breast cancer organoids—or 3D mini-tumors—to study processes involved in slowing or stopping ...

The number of Americans diagnosed with Alzheimer’s each year is expected to double by 2060, with the majority of cases affecting women.

Breastfeeding is often linked with better health for both mothers and babies, but it does not protect all women against ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

Researchers are hoping to understand how a particular DNA change can contribute to a person developing breast cancer, and why it increases the risk of the disease in men more than in women, thanks to ...

Exposing people with similar types of breast cancer to radiation alone led to changes in tumor and immune cells, paving the ...